Members of the American Medical Group Association (AMGA), which represents more than 175,000 physicians, are bullish on taking on risk, with more member revenues coming from risk-based models in 2018, according to a recent survey on the transition to value-based care.

Political unrest isn’t taking much of a toll on deals in healthcare, with executives still bullish on the sector, according to new data from Merrill Corp.

Together, private health insurance, Medicare and Medicaid accounted for 82% of total prescription drug spending in the U.S. in 2017, according to a recent analysis from the Kaiser Family Foundation that broke down drug spending that year.

Consumer goods giant Nestlé is in talks to sell its skin health business to private equity firm EQT and the Abu Dhabi Investment Authority for $10.1 billion, The Wall Street Journal reported.

National health spending reached $3.76 trillion in March 2019, a 4.6% jump from the same month in 2018, according to recent data from Altarum, underscoring signs of acceleration during the first quarter of 2019.

JPMorgan Chase has acquired InstaMed, a technology company with a focus in healthcare payments, for a purchase price of more than $500 million.

CMS finalized a rule that aims to boost transparency of the cost of prescription drugs in Medicare Part D and enable Medicare Advantage plans to negotiate better prices for medicines. Notably, the final version backs off a controversial proposal that would have allowed Medicare Part D plans to exclude certain drugs if prices rise beyond a threshold.

Physicians are bringing in more revenue at hospitals in 2019 than previously, according to a recent report from Merritt Hawkins.